Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 49,280	$ 39,744
Accounts receivable	27	17
Prepaid expenses, deposits, and other current assets	4,534	4,165
Total current assets	53,841	43,926
Fixed assets, net	2,255	2,451
Operating lease right-of-use assets	5,171	3,037
Intangible assets, net	2,940	3,445
Other assets	1,079	1,121
Total assets	65,286	53,980
Current liabilities:
Accounts payable	1,258	2,704
Accrued expenses and other current liabilities	3,724	3,705
Operating lease liabilities, current portion	1,264	1,141
Senior Secured Convertible Notes - at fair value	44,300	33,650
Total current liabilities	50,546	41,200
Operating lease liabilities, less current portion	3,936	1,846
Total liabilities	54,482	43,046
Commitments and contingencies (Note 9)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,229,887 at March 31, 2023 and 1,205,759 shares at December 31, 2022	2,767	2,695
Common stock, $0.001 par value. Authorized, 250,000,000 shares; 100,596,406 and 94,510,537 shares outstanding as of March 31, 2023 and December 31, 2022, respectively	101	95
Additional paid-in capital	221,247	216,106
Accumulated deficit	(246,172)	(228,169)
Treasury stock		(408)
Total PAVmed Inc. Stockholders’ Equity	(22,057)	(9,681)
Noncontrolling interests	32,861	20,615
Total Stockholders’ Equity	10,804	10,934
Total Liabilities and Stockholders’ Equity	$ 65,286	$ 53,980